
Qingyi Hu
Articles
-
Dec 21, 2024 |
4spepublications.onlinelibrary.wiley.com | Lin Tang |Qingyi Hu |Lizhi Li |Jing Jiang |Derun Chen |Pengcheng Zhou | +1 more
-
May 18, 2023 |
mdpi.com | Qingyi Hu |Tao Huang
Abstract:Cyclin-dependent kinases (CDKs) regulate cell division at multiple levels. Aberrant proliferation induced by abnormal cell cycle is a hallmark of cancer. Over the past few decades, several drugs that inhibit CDK activity have been created to stop the development of cancer cells. The third generation of selective CDK4/6 inhibition has proceeded into clinical trials for a range of cancers and is quickly becoming the backbone of contemporary cancer therapy.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →